Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DWS5G1
|
|||
| Drug Name |
ARO-HBV
|
|||
| Synonyms |
JNJ-3989
Click to Show/Hide
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Hepatitis B [ICD-11: 1E51; ICD-10: B18.1] | Phase 1/2 | [1] | |
| Company |
Arrowhead Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus messenger RNA (HBV mRNA) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03365947) Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Arrowhead Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.